Switching from tenofovir alafenamide to tenofovir disoproxil fumarate improves lipid profile and protects from weight gain

替诺福韦-阿拉芬酰胺 替诺福韦 医学 药理学 诺如病毒 人类免疫缺陷病毒(HIV) 化学 病毒学 病毒载量 抗逆转录病毒疗法 病毒
作者
Kai Juhani Kauppinen,Inka Aho,Jussi Sutinen
出处
期刊:AIDS [Lippincott Williams & Wilkins]
卷期号:36 (10): 1337-1344 被引量:28
标识
DOI:10.1097/qad.0000000000003245
摘要

Background: Switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) increases low-density lipoprotein cholesterol (LDL-C) and body weight. Metabolic effects of the opposite TAF-to-TDF switch are unknown. Objectives: To investigate the effect of TAF-to-TDF switch on plasma lipids, body weight, and atherosclerotic cardiovascular disease (ASCVD) risk score. Design: A retrospective chart review. Methods: One hundred and forty-six patients with TAF-to-TDF switch (Switch group) were compared with 146 patients matched for sex, age, and third antiretroviral agent class who continued unchanged TAF-containing regimen (Control group). Data were collected at approximately 1 year (follow-up FU-1) and 2 years (follow-up FU-2) after baseline values. Results: In Switch group at FU-1, total cholesterol (TC) and LDL-C decreased 12.1% and 12.4% ( P < 0.001 in both), respectively. High-density lipoprotein cholesterol (HDL-C) also decreased 8.2% ( P < 0.001) in Switch group, but TC/HDL-C ratio did not change. No statistically significant changes were observed in Control group in any lipid values. TC remained similarly decreased through FU-2 in Switch group, but LDL-C increased from FU-1 to FU-2 in both groups. ASCVD risk score decreased from 6.3% at baseline to 6.0% at FU-2 ( P = 0.012) in Switch group but increased from 8.4 to 9.1% ( P = 0.162) in Control group. Body weight increased from 83.4 kg at baseline to 84.9 kg at FU-2 ( P = 0.025) in Control group but remained stable in Switch group (83.1−83.7 kg, P = 0.978). Conclusions: TAF-to-TDF switch improved plasma lipid profile and ASCVD risk score, as well as prevented weight gain, when compared with ongoing TAF-based antiretroviral therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
茶色玻璃发布了新的文献求助10
刚刚
Owen应助科研通管家采纳,获得10
刚刚
Ava应助科研通管家采纳,获得10
刚刚
小蘑菇应助科研通管家采纳,获得10
刚刚
刚刚
丘比特应助科研通管家采纳,获得10
刚刚
刚刚
秦pale发布了新的文献求助10
刚刚
orixero应助flow采纳,获得30
1秒前
huhaoran发布了新的文献求助10
1秒前
fane发布了新的文献求助10
2秒前
随波逐流完成签到,获得积分10
2秒前
量子星尘发布了新的文献求助10
2秒前
鸭鸭完成签到,获得积分10
2秒前
2秒前
西瓜啵啵发布了新的文献求助10
2秒前
zz发布了新的文献求助10
3秒前
桔梗发布了新的文献求助10
3秒前
3秒前
3秒前
4秒前
清脆代桃完成签到 ,获得积分0
5秒前
豆子发布了新的文献求助10
5秒前
5秒前
阿辉完成签到,获得积分10
5秒前
随波逐流发布了新的文献求助10
5秒前
6秒前
大人完成签到,获得积分20
6秒前
乖猫要努力应助坚果采纳,获得10
7秒前
迷路的硬币给迷路的硬币的求助进行了留言
7秒前
酷波er应助外向的慕灵采纳,获得10
8秒前
神勇的半莲完成签到,获得积分10
8秒前
8秒前
刘亦菲完成签到,获得积分20
8秒前
茶色玻璃完成签到,获得积分10
9秒前
我是老大应助wangxipeng采纳,获得10
9秒前
傻傻的宛白完成签到,获得积分10
10秒前
ahang发布了新的文献求助10
10秒前
lynn发布了新的文献求助10
10秒前
樱悼柳雪发布了新的文献求助10
10秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971277
求助须知:如何正确求助?哪些是违规求助? 3515939
关于积分的说明 11180280
捐赠科研通 3251061
什么是DOI,文献DOI怎么找? 1795664
邀请新用户注册赠送积分活动 875937
科研通“疑难数据库(出版商)”最低求助积分说明 805209